Arcimoto Inc

Arcimoto Inc (NASDAQ: FUV) is the leading manufacturer of ultra-efficient and affordable electric vehicles.

Investment Rationale – WATCH at USD 16.13

• On the profitability front, the Company had incurred a net loss of approximately negative USD 4.7 million during Q1 FY21 as compared to negative 3.60 million for Q1 FY20.
• The Company had been widening the net loss from the last four years. Meanwhile, the consensus estimates indicated that FUV would remain loss-making for three more years.
• From a technical standpoint, the stock price is hovering around the upper Bollinger band, indicating a correction in the stock price.
• Moreover, the 14-day RSI (~60.31) is inching towards the overbought zone, indicating a correction in the stock price.

One Year Share Price Chart

 (Data Source: Refinitiv, Analysis by Kalkine Group)

Conclusion

Based on the weak profitability and unfavourable technical indicators, we have given a “WATCH” recommendation on Arcimoto Inc at the closing market price of USD 16.13 (as of 23 July 2021).

CleanSpark Inc

CleanSpark Inc (NASDAQ: CLSK) is a diversified software and intelligent energy services company.

Investment Rationale – WATCH at USD 13.48

• The Company has been consistently reporting a net loss for the last four years.
• The recent shutdown of 90% of China’s bitcoin mining capacity could have an adverse consequence on the CLSK’s operational efficiencies.
• The stock is highly volatile as it dropped by almost 50% on a YTD basis.
• From a technical standpoint, CLSK is sustaining lower than the 20-days exponential moving average of USD 14.98, indicating a correction in the stock price.

One Year Share Price Chart

 (Data Source: Refinitiv, Analysis by Kalkine Group)

Conclusion

Based on the dismal profitability and weak industry prospects, we have given a “WATCH” recommendation on CleanSpark Inc at the closing market price of USD 13.48 (as of 23 July 2021).

Spruce Biosciences Inc

Spruce Biosciences Inc (NASDAQ: SPRB) is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders.

Investment Rationale – WATCH at USD 9.55

• The operations are not commercialized, and SPRB has not reported any revenue yet.
• SPRB had reported a wider net loss during Q1 FY21 as compared to Q1 FY20. Furthermore, the consensus estimates had indicated that the Company would remain loss-making for the next four years.
• The stock price had dropped almost 48% since its debut on NASDAQ on 09 October 2020.
• From a technical standpoint, SPRB is sustaining lower than the 20-days exponential moving average of USD 10.36, indicating a correction in the stock price.

Share Price Chart (since 09 October 2020)

 (Data Source: Refinitiv, Analysis by Kalkine Group)

Conclusion

Based on the negligible top-line business and weak profitability, we have given a “WATCH” recommendation on Spruce Biosciences Inc at the closing market price of USD 9.55 (as of 23 July 2021).

Future FinTech Group Inc

Future FinTech Group Inc (NASDAQ: FTFT) is engaged in the operation of a blockchain-based online shared shopping mall platform. 

Investment Rationale – Watch at USD 2.43

• All critical profitability metrics remained negative during Q1 FY21, while the industry medians were positive.
• The Company had demonstrated a significant drop in the top-line business during FY20 as compared to FY19.
• The stock price plunged almost 77% from the YTD high of USD 10.47 reached on 17 February 2021.
• From a technical standpoint, FTFT is trading lower than the 20-days exponential moving average of USD 2.75, indicating a correction in the stock price.

One Year Share Price Chart

 (Data Source: Refinitiv, Analysis by Kalkine Group)

Conclusion

Based on the volatile nature of the stock and a drop in top-line revenue during FY20, we have given a “WATCH” recommendation on Future FinTech Group Inc at the closing market price of USD 2.43 (as of 23 July 2021).

ENGlobal Corporation

ENGlobal Corporation (NASDAQ: ENG) is the leading provider of providing engineering and professional services to the energy industry.

On 05 August, the Company will release Q2 FY21 results.

Investment Rationale – WATCH at USD 2.48

• With regards to the top-line business, the Company had posted a significant decline in revenue during Q1 FY21 due to the decline in capital and maintenance spending by its client base.
• On the profitability front, the Company had reported a substantial decrease in quarterly net income during Q1 FY21.
• On the liquidity front, the current ratio of ENG stood at 1.96x during Q1 FY21, while the industry median was 2.08x.
• From a technical standpoint, ENG is trading lower than the 20-days exponential moving average of USD 2.72, indicating a correction in the stock price.

One Year Share Price Chart

 (Data Source: Refinitiv, Analysis by Kalkine Group)

Conclusion

Based on the weak liquidity profile and poor Q1 FY21 results, we have given a “WATCH” recommendation on ENGlobal Corporation at the closing market price of USD 2.48 (as of 23 July 2021).

*The reference data in this report has been partly sourced from REFINITIV.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.